Task: Answer the MCQ question.
Question: Which compound exhibits a -29.747% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a COc1cc(C(=O)OCC(=O)N2CCOCC2)c([N+](=O)[O-])cc1OC
b Cc1cc(N)n2ncc(-c3ccc(F)cc3)c2n1
c CCC(C)(C)n1nnnc1C(C(C)C)N1CCN(C(=O)c2ccco2)CC1
d COc1ccc(-c2cccc(C3CC=CC4C3C(=O)N(Cc3ccccc3)C4c3ccc(OC)c(Cl)c3)c2)cc1
e Cc1cc(C)n2ncc(-c3cccc(Br)c3)c2n1
Answer: c. CCC(C)(C)n1nnnc1C(C(C)C)N1CCN(C(=O)c2ccco2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)(C)n1nnnc1C(C(C)C)N1CCN(C(=O)c2ccco2)CC1
CCC(C)(C)n1nnnc1C(C(C)C)N1CCN(C(=O)c2ccco2)CC1
furan-2-yl-[4-[2-methyl-1-[1-(2-methylbutan-2-yl)tetrazol-5-yl]propyl]piperazin-1-yl]methanone